Neuroendocrine tumors: prognosis, treatment and quality of care
Neuroendocriene tumoren: prognose, behandeling en kwaliteit van zorg
The first part of this thesis addresses the value of 5-hydroxyindoleacetic acid for the prognosis of small intestinal and pancreatic neuroendocrine tumors.
In the second part of this thesis the effect of treatment of neuroendocrine tumors with Lu177-DOTATATE is described. Specifically the radiological and symptomatic response are studied in patients with carcinoid syndrome, functional pancreatic neuroendocrine tumors or paragangliomas.
In the third part several quality of care items were studied, namely the importance of adherence to pathology guidelines, the pathology revision in expert centers and lastly the multidisciplinary team.
|Keywords||“Neuroendocrine tumors”, “pathology”, “5-HIAA”, “prognosis”, “therapy”, “PRRT”, “MDT”, “tumorboard”|
|Promotor||W.W. de Herder (Wouter) , R.A. Feelders (Richard)|
|Publisher||Erasmus University Rotterdam|
|Note||For copyright reasons there is a partial embargo for this dissertation|
Zandee, W.T. (2019, May 8). Neuroendocrine tumors: prognosis, treatment and quality of care. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/115841
|cover-Zandee.PNG Cover Image , 169kb|
|115841_Chapter_1-General_introduction.pdf Final Version , 842kb|
|115841_Chapter_2-Limited_value_for_urinary_5-HIAA_excreti.pdf Final Version , 384kb|
|115841_Chapter_3-Incidence_and_prognostic_value_of_seroto.pdf Final Version , 1mb|
|115841_Chapter_4-Evolution_towards_contemporary_diagnosti.pdf Final Version , 387kb|
|115841_Chapter_6-Symptomatic_and_radiological_response_to.pdf Final Version , 660kb|
|115841_Chapter_11-Discussion_and_Future_Perspectives.pdf Final Version , 324kb|